StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
AMRN

Amarin Corporation plc

AMRN Nasdaq Pharmaceutical Preparations EDGAR ↗
$14.14
-0.09 -0.63%

Key statistics

from XBRL data in SEC filings
Market cap
$5.89B
Revenue (TTM)
$186M
Net income (TTM)
-$27.1M
EPS (TTM)
$-0.07
P/E ratio
Dividend yield
Free cash flow
$6.48M
Cash
$144M
Total assets
$624M
Gross margin
42.0%
52-week range
$12.96 – $20.90

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release) Jul 29, 2026 8-K Shareholder vote results May 15, 2026 10-Q Quarter ended 2026-03-31 Apr 29, 2026 8-K Results of operations (earnings release) Apr 29, 2026 8-K Director or officer change Mar 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Results of operations (earnings release) Feb 25, 2026 8-K Results of operations (earnings release) Jan 8, 2026 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Results of operations (earnings release) Oct 29, 2025 8-K Director or officer change Oct 22, 2025 10-Q Quarter ended 2025-06-30 Jul 30, 2025 8-K Results of operations (earnings release) Jul 30, 2025 8-K/A Director or officer change Jul 3, 2025 8-K Entered a material agreement; Exit or disposal costs; Regulation FD disclosure Jun 24, 2025 8-K Shareholder vote results May 15, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Apr 29, 2025 8-K Modified rights of security holders; Regulation FD disclosure Apr 9, 2025 8-K Director or officer change Apr 7, 2025 8-K Director or officer change Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 12, 2025 8-K Results of operations (earnings release); Modified rights of security holders; Regulation FD disclosure Mar 12, 2025 8-K Director or officer change Dec 18, 2024 8-K Delisting notice or listing-rule failure Nov 22, 2024 10-Q Quarter ended 2024-09-30 Oct 30, 2024 8-K Results of operations (earnings release) Oct 30, 2024 8-K Director or officer change Oct 7, 2024 8-K Results of operations (earnings release) Jul 31, 2024 10-Q Quarter ended 2024-06-30 Jul 31, 2024 8-K Director or officer change Jul 29, 2024 8-K Director or officer change; Regulation FD disclosure Jun 4, 2024 8-K Delisting notice or listing-rule failure May 29, 2024 8-K Results of operations (earnings release) May 1, 2024 10-Q Quarter ended 2024-03-31 May 1, 2024 8-K Director or officer change; Shareholder vote results; Other events Apr 22, 2024 8-K Other events Apr 3, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024